Fate Therapeutics, Inc. (FATE)
1.17
+0.12
(+11.43%)
USD |
NASDAQ |
Jan 16, 13:22
Fate Therapeutics Market Cap: 134.96M for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals, Inc. | 2.001B |
| Palatin Technologies, Inc. | 17.03M |
| Theriva Biologics, Inc. | 6.707M |
| Oragenics, Inc. | 0.7468M |
| NanoViricides, Inc. | 21.42M |
Market Cap Related Metrics
| PS Ratio | 19.41 |
| Price to Book Value | 0.5766 |
| Price | 1.17 |
| Earnings Yield | -112.7% |